Table 2.
Demographic characteristics of study subjects for the placebo group
| GG | GC | CC | P valuea | |
|---|---|---|---|---|
| Number | 4 (11%) | 13 (35%) | 20 (54%) | |
| Age, years | 34.8 ± 9.8 | 31.5 ± 6.2 | 30.1 ± 4.5 | 0.145 |
| Gender, % male | 25.0 | 76.9 | 45.0 | 0.093 |
| Height, cm | 162.0 ± 7.4 | 168.2 ± 8.1 | 166.6 ± 9.4 | 0.631 |
| Weight at baseline, kg | 76.6 ± 10.8 | 82.4 ± 15.1 | 85.2 ± 15.8 | 0.299 |
| BMI at baseline, kg/m2 | 29.1 ± 1.6 | 28.9 ± 3.1 | 30.5 ± 3.8 | 0.128 |
| Percent body fat at baseline,% | 36.3 ± 4.0 | 31.8 ± 3.9 | 35.6 ± 5.7 | 0.420 |
Data are presented as mean ± standard deviation.
a
P values refer to ANOVA analyses for continuous variables and the χ2 test for the categorical data.
Abbreviation: BMI, body mass index.